{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:50:25Z","timestamp":1768974625920,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T00:00:00Z","timestamp":1354147200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1038\/hr.2012.187","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T07:00:38Z","timestamp":1354172438000},"page":"342-348","source":"Crossref","is-referenced-by-count":28,"title":["Powerful vascular protection by combining cilnidipine with valsartan in stroke-prone, spontaneously hypertensive rats"],"prefix":"10.1038","volume":"36","author":[{"given":"Shinji","family":"Takai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuka","family":"Aritomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Niinuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuo","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,29]]},"reference":[{"key":"BFhr2012187_CR1","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1161\/01.RES.74.6.1141","volume":"74","author":"KK Griendling","year":"1994","unstructured":"Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW . Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74: 1141\u20131148.","journal-title":"Circ Res"},{"key":"BFhr2012187_CR2","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1172\/JCI118623","volume":"97","author":"S Rajagopalan","year":"1996","unstructured":"Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG . Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH\/-NAD(P)H oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 1996; 97: 1916\u20131923.","journal-title":"J Clin Invest"},{"key":"BFhr2012187_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/01.HYP.0000113627.08110.6f","volume":"43","author":"T Jinno","year":"2004","unstructured":"Jinno T, Iwai M, Li Z, Li JM, Liu HW, Cui TX, Rakugi H, Ogihara T, Horiuchi M . Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan. Hypertension 2004; 43: 263\u2013269.","journal-title":"Hypertension"},{"key":"BFhr2012187_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/ajh.2008.344","volume":"22","author":"S Inaba","year":"2009","unstructured":"Inaba S, Iwai M, Tomono Y, Senba I, Furuno M, Kanno H, Okayama H, Mogi M, Higaki J, Horiuchi M . Prevention of vascular injury by combination of an AT1 receptor blocker, olmesartan, with various calcium antagonists. Am J Hypertens 2009; 22: 145\u2013150.","journal-title":"Am J Hypertens"},{"key":"BFhr2012187_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/hr.2010.224","volume":"34","author":"S Takai","year":"2011","unstructured":"Takai S, Jin D, Shimosato T, Sakonjo H, Miyazaki M . Candesartan and amlodipine combination therapy provides powerful vascular protection in stroke-prone spontaneously hypertensive rats. Hypertens Res 2011; 34: 245\u2013252.","journal-title":"Hypertens Res"},{"key":"BFhr2012187_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1161\/01.RES.0000256155.31133.49","volume":"100","author":"K Hayashi","year":"2007","unstructured":"Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T . Ca2+ channel subtypes and pharmacology in the kidney. Circ Res 2007; 100: 342\u2013353.","journal-title":"Circ Res"},{"key":"BFhr2012187_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.jdiacomp.2006.06.001","volume":"21","author":"T Fujisawa","year":"2007","unstructured":"Fujisawa T, Ikegami H, Noso S, Hiromine Y, Kawabata Y, Nishino M, Asano K, Ogihara T . Renoprotective effect of N-type Ca channel blockade in diabetic nephropathy. J Diabetes Complications 2007; 21: 252\u2013257.","journal-title":"J Diabetes Complications"},{"key":"BFhr2012187_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/hr.2010.279","volume":"34","author":"H Toba","year":"2011","unstructured":"Toba H, Yoshida M, Tojo C, Nakano A, Oshima Y, Kojima Y, Noda K, Wang J, Kobara M, Nakata T . L\/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats. Hypertens Res 2011; 34: 521\u2013529.","journal-title":"Hypertens Res"},{"key":"BFhr2012187_CR9","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1097\/00004872-200111000-00014","volume":"19","author":"M Honda","year":"2001","unstructured":"Honda M, Hayashi K, Matsuda H, Kubota E, Tokuyama H, Okubo K, Takamatsu I, Ozawa Y, Saruta T . Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo. J Hypertens 2001; 19: 2031\u20132037.","journal-title":"J Hypertens"},{"key":"BFhr2012187_CR10","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/hr.2010.90","volume":"33","author":"S Takai","year":"2010","unstructured":"Takai S, Jin D, Sakonjo H, Miyazaki M . Combination therapy with irbesartan and efonidipine for attenuation of proteinuria in Dahl salt-sensitive rats. Hypertens Res 2010; 33: 953\u2013959.","journal-title":"Hypertens Res"},{"key":"BFhr2012187_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1126\/science.2447647","volume":"239","author":"LD Hirning","year":"1988","unstructured":"Hirning LD, Fox AP, McCleskey EW, Olivera BM, Thayer SA, Miller RJ, Tsien RW . Dominant role of N-type Ca2+ channels in evoked release of noradrenaline from sympathetic neurons. Science 1988; 239: 57\u201361.","journal-title":"Science"},{"key":"BFhr2012187_CR12","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1097\/HJH.0b013e3282c2fa62","volume":"25","author":"S Morimoto","year":"2007","unstructured":"Morimoto S, Yano Y, Maki K, Iwasaka T . Renal and vascular protective effects of cilnidipine in patients with essential hypertension. J Hypertens 2007; 25: 2178\u20132183.","journal-title":"J Hypertens"},{"key":"BFhr2012187_CR13","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/hr.2009.116","volume":"32","author":"S Takai","year":"2009","unstructured":"Takai S, Jin D, Ikeda H, Sakonjo H, Miyazaki M . Significance of angiotensin II receptor blockers with high affinity to angiotensin II type 1 receptors for vascular protection in rats. Hypertens Res 2009; 32: 853\u2013860.","journal-title":"Hypertens Res"},{"key":"BFhr2012187_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1254\/jphs.11053FP","volume":"116","author":"S Takai","year":"2011","unstructured":"Takai S, Jin D, Miyazaki M . Irbesartan prevents metabolic syndrome in rats via activation of peroxisome proliferator-activated receptor \u03b3. J Pharmacol Sci 2011; 116: 309\u2013315.","journal-title":"J Pharmacol Sci"},{"key":"BFhr2012187_CR15","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1124\/jpet.111.182576","volume":"339","author":"YF Dong","year":"2011","unstructured":"Dong YF, Kataoka K, Tokutomi Y, Nako H, Nakamura T, Toyama K, Sueta D, Koibuchi N, Yamamoto E, Ogawa H, Kim-Mitsuyama S . Beneficial effects of combination of valsartan and amlodipine on salt-induced brain injury in hypertensive rats. J Pharmacol Exp Ther 2011; 339: 358\u2013866.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFhr2012187_CR16","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1161\/01.HYP.33.6.1353","volume":"33","author":"S Kerr","year":"1999","unstructured":"Kerr S, Brosnan MJ, McIntyre M, Reid JL, Dominiczak AF, Hamilton CA . Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium. Hypertension 1999; 33: 1353\u20131358.","journal-title":"Hypertension"},{"key":"BFhr2012187_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00004872-200202000-00018","volume":"20","author":"MJ Brosnan","year":"2002","unstructured":"Brosnan MJ, Hamilton CA, Graham D, Lygate CA, Jardine E, Dominiczak AF . Irbesartan lowers superoxide levels and increases nitric oxide bioavailability in blood vessels from spontaneously hypertensive stroke-prone rats. J Hypertens 2002; 20: 281\u2013286.","journal-title":"J Hypertens"},{"key":"BFhr2012187_CR18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1291\/hypres.28.593","volume":"28","author":"S Takai","year":"2005","unstructured":"Takai S, Kirimura K, Jin D, Muramatsu M, Yoshikawa K, Mino Y, Miyazaki M . Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling. Hypertens Res 2005; 28: 593\u2013600.","journal-title":"Hypertens Res"},{"key":"BFhr2012187_CR19","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1161\/01.RES.0000033523.08033.16","volume":"91","author":"PN Seshiah","year":"2002","unstructured":"Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK . Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 2002; 91: 406\u2013413.","journal-title":"Circ Res"},{"key":"BFhr2012187_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1161\/01.RES.80.1.45","volume":"80","author":"T Fukui","year":"1997","unstructured":"Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q, Taylor WR, Harrison DG, de Leon H, Wilcox JN, Griendling KK . p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 1997; 80: 45\u201351.","journal-title":"Circ Res"},{"key":"BFhr2012187_CR21","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1161\/01.HYP.0000037063.90643.0B","volume":"40","author":"CA Hamilton","year":"2002","unstructured":"Hamilton CA, Brosnan MJ, Al-Benna S, Berg G, Dominiczak AF . NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels. Hypertension 2002; 40: 755\u2013762.","journal-title":"Hypertension"},{"key":"BFhr2012187_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/ki.2009.146","volume":"76","author":"K Hishikawa","year":"2009","unstructured":"Hishikawa K, Takase O, Idei M, Fujita T . Comparison of antioxidant activity of cilnidipine and amlodipine. Kidney Int 2009; 76: 230\u2013231.","journal-title":"Kidney Int"},{"key":"BFhr2012187_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1471-4159.2009.06297.x","volume":"111","author":"YJ Lee","year":"2009","unstructured":"Lee YJ, Park KH, Park HH, Kim YJ, Lee KY, Kim SH, Koh SH . Cilnidipine mediates a neuroprotective effect by scavenging free radicals and activating the phosphatidylinositol 3-kinase pathway. J Neurochem 2009; 111: 90\u2013100.","journal-title":"J Neurochem"},{"key":"BFhr2012187_CR24","doi-asserted-by":"publisher","first-page":"H183","DOI":"10.1152\/ajpheart.01040.2007","volume":"294","author":"H Macarthur","year":"2008","unstructured":"Macarthur H, Westfall TC, Wilken GH . Oxidative stress attenuates NO-induced modulation of sympathetic neurotransmission in the mesenteric arterial bed of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2008; 294: H183\u2013H189.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFhr2012187_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/HJH.0b013e3280115b96","volume":"25","author":"K Miyagawa","year":"2007","unstructured":"Miyagawa K, Ohashi M, Yamashita S, Kojima M, Sato K, Ueda R, Dohi Y . Increased oxidative stress impairs endothelial modulation of contractions in arteries from spontaneously hypertensive rats. J Hypertens 2007; 25: 415\u2013421.","journal-title":"J Hypertens"},{"key":"BFhr2012187_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1161\/01.HYP.27.3.523","volume":"27","author":"KB Brosnihihan","year":"1996","unstructured":"Brosnihihan KB, Li P, Ferrario CM . Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide. Hypertension 1996; 27: 523\u2013528.","journal-title":"Hypertension"},{"key":"BFhr2012187_CR27","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, Donovan M, Woolf B, Robison K, Jeyaseelan R, Breitbart RE, Acton S . A novel angiotensin-converting enzyme\u2212related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87: e1\u2013e9.","journal-title":"Circ Res"},{"key":"BFhr2012187_CR28","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1161\/HYPERTENSIONAHA.107.102764","volume":"51","author":"P Xu","year":"2008","unstructured":"Xu P, Costa-Goncalves AC, Todiras M, Rabelo LA, Sampaio WO, Moura MM, Santos SS, Luft FC, Bader M, Gross V, Alenina N, Santos RA . Endothelial dysfunction and elevated blood pressure in Mas gene-deleted mice. Hypertension 2008; 51: 574\u2013580.","journal-title":"Hypertension"},{"key":"BFhr2012187_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/hr.2010.235","volume":"34","author":"LA Rabelo","year":"2011","unstructured":"Rabelo LA, Alenina N, Bader M . ACE2-angiotensin-(1\u20137)-Mas axis and oxidative stress in cardiovascular disease. Hypertens Res 2011; 34: 154\u2013160.","journal-title":"Hypertens Res"},{"key":"BFhr2012187_CR30","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","volume":"43","author":"Y Ishiyama","year":"2004","unstructured":"Ishiyama Y, Gallagher PE, Averill DB, Tallant EA, Brosnihan KB, Ferrario CM . Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 2004; 43: 970\u2013976.","journal-title":"Hypertension"},{"key":"BFhr2012187_CR31","doi-asserted-by":"publisher","first-page":"H1013","DOI":"10.1152\/ajpheart.00068.2005","volume":"289","author":"M Igase","year":"2005","unstructured":"Igase M, Strawn WB, Gallagher PE, Geary RL, Ferrario CM . Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2005; 289: H1013\u2013H1019.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFhr2012187_CR32","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1159\/000210396","volume":"30","author":"T Konda","year":"2009","unstructured":"Konda T, Enomoto A, Aritomi S, Niinuma K, Koganei H, Ogawa T, Nitta K . Different effects of L\/N-type and L-type calcium channel blockers on the renin-angiotensin-aldosterone system in SHR\/Izm. Am J Nephrol 2009; 30: 155\u2013161.","journal-title":"Am J Nephrol"},{"key":"BFhr2012187_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000323969","volume":"33","author":"S Aritomi","year":"2011","unstructured":"Aritomi S, Niinuma K, Ogawa T, Konda T, Nitta K . Effects of an N-type calcium antagonist on angiotensin II-renin feedback. Am J Nephrol 2011; 33: 168\u2013175.","journal-title":"Am J Nephrol"},{"key":"BFhr2012187_CR34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1161\/01.HYP.38.1.95","volume":"38","author":"B Tom","year":"2001","unstructured":"Tom B, de Vries R, Saxena PR, Danser AH . Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade. Hypertension 2001; 38: 95\u201399.","journal-title":"Hypertension"},{"key":"BFhr2012187_CR35","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jtcvs.2010.01.048","volume":"141","author":"L Fan","year":"2011","unstructured":"Fan L, Yang Q, Xiao XQ, Grove KL, Huang Y, Chen ZW, Furnary A, He GW . Dual actions of cilnidipine in human internal thoracic artery: inhibition of calcium channels and enhancement of endothelial nitric oxide synthase. J Thorac Cardiovasc 2011; 141: 1063\u20131069.","journal-title":"J Thorac Cardiovasc"},{"key":"BFhr2012187_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ejphar.2011.03.028","volume":"659","author":"A Sharma","year":"2011","unstructured":"Sharma A, Trane A, Yu C, Jasmin JF, Bernatchez P . Amlodipine increases endothelial nitric oxide release by modulating binding of native eNOS protein complex to caveolin-1. Eur J Pharmacol 2011; 659: 206\u2013212.","journal-title":"Eur J Pharmacol"},{"key":"BFhr2012187_CR37","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1291\/hypres.26.609","volume":"26","author":"T Takami","year":"2003","unstructured":"Takami T, Shigemasa M . Efficacy of various antihypertensive agents as evaluated by indices of vascular stiffness in elderly hypertensive patients. Hypertens Res 2003; 26: 609\u2013614.","journal-title":"Hypertens Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/hr2012187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2012187","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/hr2012187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:10:49Z","timestamp":1684429849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/hr2012187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,29]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["BFhr2012187"],"URL":"https:\/\/doi.org\/10.1038\/hr.2012.187","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,29]]}}}